• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


Future of Astellas

Quote


















FDA website - FAERS - for Astellas eye product acquired from Iveric - Izervay. Ouch- a drug with a 12 month indication and a ton of FAERS. If ya don’t know what that means - look it up. Buckle your seatbelt - and Hold on to your seats - things about to get wild around here.
 






anonymous said:
FDA website - FAERS - for Astellas eye product acquired from Iveric - Izervay. Ouch- a drug with a 12 month indication and a ton of FAERS. If ya don’t know what that means - look it up. Buckle your seatbelt - and Hold on to your seats - things about to get wild around here.
Click to expand...
That was back in November
 












anonymous said:
FDA website - FAERS - for Astellas eye product acquired from Iveric - Izervay. Ouch- a drug with a 12 month indication and a ton of FAERS. If ya don’t know what that means - look it up. Buckle your seatbelt - and Hold on to your seats - things about to get wild around here.
Click to expand...
All reported by Cedric personally.
Totally legit right?
Ouch. Sucks to work at Apellis.
 
















































The only bright spots in the company where treatments are helping patients and the future might be sustainable would be oncology and retina. If you aren’t in one of those areas I’d be contemplating my next move. Hopefully someone can turn the ship with the pipeline and whoever is at the top with Veozah, you should find a new career. Cut that baby and call it a loss. The entire team leading data and forecasting should be cleaned out. You can’t run a successful business with lousy forecasting based on horrible data and insights. TAKE A CHANCE ON SOME NEW PEOPLE AND QUIT PROMOTING THE SAME OLD SAME OLD THAT PROVIDE NO VALUE TO ANYONE!!!
 






anonymous said:
The only bright spots in the company where treatments are helping patients and the future might be sustainable would be oncology and retina. If you aren’t in one of those areas I’d be contemplating my next move. Hopefully someone can turn the ship with the pipeline and whoever is at the top with Veozah, you should find a new career. Cut that baby and call it a loss. The entire team leading data and forecasting should be cleaned out. You can’t run a successful business with lousy forecasting based on horrible data and insights. TAKE A CHANCE ON SOME NEW PEOPLE AND QUIT PROMOTING THE SAME OLD SAME OLD THAT PROVIDE NO VALUE TO ANYONE!!!
Click to expand...
No future in Retina, the damage is done
 
























Top Bottom
Back
Quote